title: Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease.
authors.forename: M
authors.initials: M
authors.lastname: Miura
authors.forename: H
authors.initials: H
authors.lastname: Ohki
authors.forename: S
authors.initials: S
authors.lastname: Yoshiba
authors.forename: H
authors.initials: H
authors.lastname: Ueda
authors.forename: A
authors.initials: A
authors.lastname: Sugaya
authors.forename: M
authors.initials: M
authors.lastname: Satoh
authors.forename: H
authors.initials: H
authors.lastname: Yamagishi
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects*; D009080:Mucocutaneous Lymph Node Syndrome / Q000188:drug therapy*; D020551:Pulse Therapy, Drug
chemical_list: D000925:Anticoagulants; D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D006493:Heparin; D008775:Methylprednisolone